5-Bromo-4-chloro-6-(5-fluorofuran-2-yl)thieno[2,3-d]pyrimidine

Catalog No. :
ACYPBC781
CAS No. :
1799610-97-1
Molecular Formula :
C10H3BrClFN2OS
Molecular Weight :
333.57

IUPAC Name:5-bromo-4-chloro-6-(5-fluorofuran-2-yl)thieno[2,3-d]pyrimidine

5-Bromo-4-chloro-6-(5-fluorofuran-2-yl)thieno[2,3-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg85%$57.00Login to see priceInquiryInquiry
250mg85%$95.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-4-chloro-6-(5-fluorofuran-2-yl)thieno[2,3-d]pyrimidine
IUPAC Name5-bromo-4-chloro-6-(5-fluorofuran-2-yl)thieno[2,3-d]pyrimidine
MDL No.MFCD31558277
Molecular FormulaC10H3BrClFN2OS
Molecular Weight333.57
SMILESFC1=CC=C(C2=C(Br)C3=C(Cl)N=CN=C3S2)O1
InChI KeyOEBAPNYAYMNZBF-UHFFFAOYSA-N
Synonym5-bromo-4-chloro-6-(5-fluorofuran-2-yl)thieno[2,3-d]pyrimidine;Thieno[2,3-d]pyrimidine, 5-bromo-4-chloro-6-(5-fluoro-2-furanyl)-;5-Bromo-4-chloro-6-(5-fluoro-2-furanyl)thieno[2,3-d]pyrimidine
CAS No.1799610-97-1
PubChem CID118157043

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACYPBC781 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCOTY701 route compound structure diagram
    ACCOTY7011799610-89-1 In Stock
  4. Then
  5. ACYPBC781 route product structure diagram
    ACYPBC7811799610-97-1
Inquiry

2. ACYPBC781 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCOTY701 route compound structure diagram
    ACCOTY7011799610-89-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYPBC781 route product structure diagram
    ACYPBC7811799610-97-1
Inquiry

Comments (0)